List view / Grid view

GlaxoSmithKline (GSK)

 

article

The circuit of life: saving on manufacturing, waste and delivery-related supply chain inefficiencies

26 June 2020 | By ,

Many pharmaceutical companies have complicated supply chains that are inefficient and ill-equipped to deal with current demands. This article explores how digitalising the healthcare supply chain can address the pharmaceutical sector's increasing financial-, capacity- and waste-related strains associated with our ageing population and the soaring costs of new treatments.